Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: Impact of salvage therapy on local disease control

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 4, 2014, Pages 822-828

  Habr Gama, Angelita ^a,b   Gama Rodrigues, Joaquim ^a,b   São Julião, Guilherme P ^a,b   Proscurshim, Igor ^a   Sabbagh, Charles ^a   Lynn, Patricio B ^a   Perez, Rodrigo O ^a,c  

^a Angelita and Joaquim Gama Institute   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMORADIATION THERAPIES; DISEASE FREE SURVIVAL; FOLLOW-UP PROGRAMS; INITIAL ASSESSMENT; LOCAL DISEASE CONTROLS; METHODS AND MATERIALS; NEOADJUVANT CHEMORADIATION; RECURRENCE-FREE SURVIVAL;

CHEMORADIOTHERAPY; CHEMOTHERAPY; DISEASES;

WATCHES;

FLUOROURACIL;

ADULT; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; SALVAGE THERAPY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR GROWTH;

ALGORITHMS; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGAN SPARING TREATMENTS; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; SALVAGE THERAPY; TUMOR BURDEN; WATCHFUL WAITING;

EID: 84896708427     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.12.012     Document Type: Article

References (17)

1. P. Sanghera, D.W. Wong, and C.C. McConkey et al. Chemoradiotherapy for rectal cancer: An updated analysis of factors affecting pathological response Clin Oncol (R Coll Radiol) 20 2008 176 183
2. M. Maas, P.J. Nelemans, and V. Valentini et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data Lancet Oncol 11 2010 835 844
3. F.M. Smith, D. Waldron, and D.C. Winter Rectum-conserving surgery in the era of chemoradiotherapy Br J Surg 97 2010 1752 1764
4. R. Hughes, R. Glynne-Jones, and J. Grainger et al. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int J Colorectal Dis 21 2006 11 17
5. J. Garcia-Aguilar, Q. Shi, and C.R. Thomas Jr. et al. A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: Preliminary results of the ACOSOG Z6041 trial Ann Surg Oncol 19 2012 384 391
6. J.H. Marks, E.B. Valsdottir, and A. DeNittis et al. Transanal endoscopic microsurgery for the treatment of rectal cancer: Comparison of wound complication rates with and without neoadjuvant radiation therapy Surg Endosc 23 2009 1081 1087
7. R.O. Perez, A. Habr-Gama, and G.P. Sao Juliao et al. Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates Dis Colon Rectum 54 2011 545 551
8. A. Habr-Gama, R.O. Perez, and W. Nadalin et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results Ann Surg 240 2004 711 717 discussion 711-718
9. M. Maas, R.G. Beets-Tan, and D.M. Lambregts et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer J Clin Oncol 29 2011 4633 4640
10. A. Habr-Gama, R.O. Perez, and G. Wynn et al. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: Characterization of clinical and endoscopic findings for standardization Dis Colon Rectum 53 2010 1692 1698
11. A. Habr-Gama, R.O. Perez, and I. Proscurshim et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy J Gastrointest Surg 10 2006 1319 1328 discussion 1328-1329
12. A. Habr-Gama, R.O. Perez, and J. Sabbaga et al. Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: Results of a prospective study using additional chemotherapy during the resting period Dis Colon Rectum 52 2009 1927 1934
13. E.D. Mignanelli, L.F. de Campos-Lobato, and L. Stocchi et al. Downstaging after chemoradiotherapy for locally advanced rectal cancer: Is there more (tumor) than meets the eye? Dis Colon Rectum 53 2010 251 256
14. K. Bujko, M.P. Nowacki, and A. Nasierowska-Guttmejer et al. Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: Results of a randomised trial: Implication for subsequent local excision Radiother Oncol 76 2005 234 240
15. D.W. Kim, D.Y. Kim, and T.H. Kim et al. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Cancer 106 2006 1694 1700
16. A. Habr-Gama, R.O. Perez, and W. Nadalin et al. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival J Gastrointest Surg 9 2005 90 99 discussion 99-101
17. E. Lezoche, M. Guerrieri, and A. Paganini et al. Is transanal endoscopic microsurgery (TEM) a valid treatment for rectal tumors? Surg Endosc 10 1996 736 741